Published in J Gastrointest Oncol on October 01, 2014
An endoscope with integrated transparent bioelectronics and theranostic nanoparticles for colon cancer treatment. Nat Commun (2015) 1.11
Robust evidence for long-term survival with (90)Y radioembolization in chemorefractory liver-predominant metastatic colorectal cancer. Eur Radiol (2016) 0.78
Simultaneous hepatic resection benefits patients with synchronous colorectal cancer liver metastases. Chin J Cancer Res (2016) 0.77
Staged resection of bilobar colorectal liver metastases: surgical strategies. Langenbecks Arch Surg (2015) 0.76
Analysis of liver-directed therapies in U.S. cancer patients. Curr Oncol (2015) 0.75
Increased expression of Rab5A predicts metastasis and poor prognosis in colorectal cancer patients. Int J Clin Exp Pathol (2015) 0.75
Rectal cancer: a truly multidisciplinary challenge. J Gastrointest Oncol (2014) 0.75
Targeted exome sequencing reveals distinct pathogenic variants in Iranians with colorectal cancer. Oncotarget (2017) 0.75
Impact of Systemic Therapy and Recurrence Pattern on Survival Outcome after Radiofrequency Ablation for Colorectal Liver Metastases. J Cancer (2016) 0.75
Potent anti-tumor effects of EGFR-targeted hybrid peptide on mice bearing liver metastases. Clin Exp Metastasis (2016) 0.75
Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg (2012) 19.78
Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin (2012) 14.47
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg (1999) 14.31
Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg (2004) 6.75
Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg (2002) 6.24
Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol (2006) 5.78
Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg (2004) 5.10
Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg (2005) 4.86
Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol (2009) 4.59
Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16
Resection of hepatic metastases from colorectal cancer. Arch Surg (1984) 4.06
Playing Play-Doh to prevent postoperative liver failure: the "ALPPS" approach. Ann Surg (2012) 3.87
Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology (2001) 3.85
Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery (1991) 3.35
Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg (2008) 3.33
Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg (2006) 3.05
Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol (2009) 2.99
Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg (2007) 2.96
Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol (2006) 2.96
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol (2013) 2.94
Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol (2003) 2.85
Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol (1999) 2.80
Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg (2004) 2.65
Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg (2002) 2.62
Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg (2007) 2.62
Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery (2000) 2.55
Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases. J Clin Oncol (2008) 2.52
Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol (2000) 2.51
Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann Surg (2009) 2.44
Portal vein embolization: rationale, technique and future prospects. Br J Surg (2001) 2.41
During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg (1999) 2.37
Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg (2000) 2.32
High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol (2011) 2.28
Survival after radiofrequency ablation of colorectal liver metastases: 10-year experience. Ann Surg (2007) 2.28
A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg (2004) 2.20
Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors. Dis Colon Rectum (1988) 2.20
Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg (2003) 2.13
Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg (1997) 2.13
Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg (2008) 2.10
Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases. Am J Surg (2008) 2.09
Solitary colorectal liver metastasis: resection determines outcome. Arch Surg (2006) 2.06
Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg (2004) 2.01
Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel. Ann Oncol (2009) 1.93
Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer. Ann Surg Oncol (2006) 1.87
Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis. Cancer (2011) 1.87
Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann Surg (2008) 1.85
Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Phys (2006) 1.84
Impact of portal vein embolization on long-term survival of patients with primarily unresectable colorectal liver metastases. Br J Surg (2010) 1.73
Studies on the blood supply of tumors in man. III. Vascular patterns of the liver by hepatic arteriography in vivo. J Natl Cancer Inst (1951) 1.72
Predicting poor outcome following hepatectomy: analysis of 2313 hepatectomies in the NSQIP database. HPB (Oxford) (2009) 1.70
A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer (1992) 1.68
Unresectable colorectal cancer liver metastases treated by intraoperative radiofrequency ablation with or without resection. Br J Surg (2012) 1.59
Long-term outcomes following tumor ablation for treatment of bilateral colorectal liver metastases. JAMA Surg (2013) 1.58
Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. Ann Oncol (2004) 1.56
Hepatic resection for metastatic colorectal cancer. Am Surg (1997) 1.55
Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors. Arch Surg (2001) 1.54
Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): tips and tricks. J Gastrointest Surg (2012) 1.53
Portal vein embolization before liver resection: a systematic review. Cardiovasc Intervent Radiol (2012) 1.50
Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. J Clin Oncol (2009) 1.50
Remnant liver volume to body weight ratio > or =0.5%: A new cut-off to estimate postoperative risks after extended resection in noncirrhotic liver. J Am Coll Surg (2006) 1.48
In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection. Br J Surg (2012) 1.45
Microwave ablation for hepatic malignancies: a multiinstitutional analysis. Ann Surg (2014) 1.44
Repeat curative intent liver surgery is safe and effective for recurrent colorectal liver metastasis: results from an international multi-institutional analysis. J Gastrointest Surg (2009) 1.41
Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases. Br J Cancer (2010) 1.39
Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg (1999) 1.39
Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy. J Vasc Interv Radiol (2007) 1.39
Changes in hepatic lobar function after right portal vein embolization. An appraisal by biliary indocyanine green excretion. Ann Surg (1996) 1.35
Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg (2007) 1.35
Stereotactic body radiation therapy for colorectal liver metastases. Br J Surg (2010) 1.35
Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results. Anticancer Res (2006) 1.32
Portal vein embolization with polyvinyl alcohol particles and coils in preparation for major liver resection for hepatobiliary malignancy: safety and effectiveness--study in 26 patients. Radiology (2003) 1.32
ALPPS in right trisectionectomy: a safe procedure to avoid postoperative liver failure? J Gastrointest Surg (2013) 1.32
A theoretical comparison of energy sources--microwave, ultrasound and laser--for interstitial thermal therapy. Phys Med Biol (1998) 1.30
Simultaneous versus staged resection for synchronous colorectal cancer liver metastases. J Am Coll Surg (2009) 1.23
Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: a critical appraisal of the 1cm rule. Eur J Surg Oncol (2006) 1.23
A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases. Eur J Cancer (2009) 1.23
Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study. Anticancer Res (2012) 1.22
Resection margin and recurrence-free survival after liver resection of colorectal metastases. Ann Surg Oncol (2009) 1.21
Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases. Ann Surg Oncol (2008) 1.20
A comparative histological evaluation of the ablations produced by microwave, cryotherapy and radiofrequency in the liver. Pathology (2009) 1.20
Rates and patterns of recurrence for percutaneous radiofrequency ablation and open wedge resection for solitary colorectal liver metastasis. J Gastrointest Surg (2007) 1.19
Microwaves create larger ablations than radiofrequency when controlled for power in ex vivo tissue. Med Phys (2010) 1.18
Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm. Arch Surg (2000) 1.18
Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases? Ann Surg (2010) 1.18
Liver resection for colorectal metastases in presence of extrahepatic disease: results from an international multi-institutional analysis. Ann Surg Oncol (2010) 1.16
Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis. Ann Surg Oncol (2012) 1.15
Surgical management of patients with synchronous colorectal liver metastasis: a multicenter international analysis. J Am Coll Surg (2013) 1.14
Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases. J Vasc Interv Radiol (2008) 1.14
Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery. Ann Surg Oncol (2007) 1.14
Concomitant extrahepatic disease in patients with colorectal liver metastases: when is there a place for surgery? Ann Surg (2011) 1.12
Effect of subcentimeter nonpositive resection margin on hepatic recurrence in patients undergoing hepatectomy for colorectal liver metastases. Evidences from 663 liver resections. Ann Oncol (2007) 1.12
Radiofrequency ablation permits an effective treatment for colorectal liver metastasis. Eur J Surg Oncol (2006) 1.12
Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases. J Am Coll Surg (2005) 1.11
Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma. J Clin Oncol (1994) 1.10
Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements. HPB (Oxford) (2013) 1.08
Hepatic microwave ablation: a review of the histological changes following thermal damage. Liver Int (2008) 1.06
Two-stage hepatectomy approach for initially unresectable colorectal hepatic metastases. Surg Oncol Clin N Am (2007) 1.03